The second point is that in recurrent/chronic tonsillitis accompanied with vitamin D deficiency, VEGF levels can be a new therapeutic target to limit vasculogenesis associated with chronic inflammation. This evidence concerns the gene VEGFA and Recurrent tonsillitis.